Monopar Therapeutics (MNPR) EPS (2017 - 2026)
Monopar Therapeutics (MNPR) EPS from Dec 31, 2017 to Mar 31, 2026. The TTM Monopar Therapeutics (MNPR) EPS is -$2.27. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Monopar Therapeutics (MNPR) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -26.10% |
| 3 Years TTM | -17.56% |
| 5 Years TTM | -5.82% |
| All Time TTM | +4.60% |
Annual EPS change of Monopar Therapeutics (MNPR)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.58 | -71.68% |
| 2025 | -$2.05 | -19.75% |
| 2024 | -$2.55 | -9.34% |
| 2023 | -$2.82 | -30.64% |
| 2022 | -$4.06 | +12.49% |
| 2021 | -$3.61 | +31.32% |
| 2020 | -$2.75 | +38.00% |
| 2019 | -$1.99 | +473.28% |
| 2018 | -$0.35 | -80.48% |
| 2017 | -$1.78 | N/A |
Comparison Monopar Therapeutics (MNPR) five years EPS CAGR with competitors
Monopar Therapeutics (MNPR) five years EPS CAGR is -5.81%.